Ionis Pharmaceuticals stock (NASDAQ: IONS) is trading higher this morning, up 2.18% in the pre-market. Confidence is growing, with analysts projecting a clearer path to profitability ahead.

Lantheus Holdings' stock (NASDAQ: LNTH) is dealing with some analyst cuts, primarily stemming from performance concerns surrounding its key product, Pylarify. Recent downgrades, including one this morning, have impacted marke

Delta Air Lines, Inc. (DAL) is set to release its third-quarter earnings report on Thursday, a pivotal moment for those seeking to gauge the airline's trajectory amidst a complex economic landscape. The Delta stock price has

Intel's stock (NASDAQ: INTC) has been on a tear over the past month, adding 51.84% on the period, as bullish sentiment has pushed INTC higher. There could be some headwinds on the horizon, with a contrarian call from HSBC, do

PepsiCo's stock (PEP) has offered precious little to holders this year, declining 6.27% YTD, and 0.65% over the past month, as broader markets have rallied. The stock's underperformance raises concerns as the company approach

Rentokil Initial (LON: RTO) shares rose sharply on Tuesday after Bernstein double upgraded the pest control and hygiene group to Outperform from Underperform, citing signs of improving organic revenue growth.

IP Group plc (LSE: IPO) shares have risen 2.8% on Wednesday following the announcement that its portfolio company, Monolith Ltd, is being acquired by Nasdaq-listed CoreWeave, Inc.

On Wednesday, Foresight Group Holdings (LON: FGH) announced a positive trading update for the first half of fiscal year 2026, demonstrating sustained investor appetite for its specialist investment products.

Greencore Group plc (LON: GNR), a leading UK convenience food manufacturer, saw its share price rise on Wednesday after it upgraded its full-year adjusted operating profit guidance following a robust fourth quarter and a stro

Aptamer Group PLC (AIM: APTA), a developer of synthetic binders for the life sciences, announced a significant contract win with a top 3 global pharmaceutical company, sending positive signals to the market.

ANGLE (AIM:AGL), a precision circulating tumor cell (CTC) intelligence company, has announced a strategic overhaul, including the appointment of Dr. Jan Groen as Executive Chairman and a proposed name change to CelLBxHealth p

Tilray Brands' stock (NASDAQ: TLRY) is currently trading around $1.71 in pre-maket hours, up 8.23% yesterday, and riding the wave of a significant 52% surge over the past month.

Marston's PLC (LON: MARS) is trading higher following a trading update for the 52 weeks ended September 27, 2025, revealing that underlying profit before tax is expected to surpass market expectations.

Anglo American (LON: AAL) has responded to Teck Resources' (NYSE: TECK) completion of its comprehensive operational review and updated outlook, reiterating its support for the proposed merger announced on September 9, 2025.

Applied Digital's stock (NASDAQ: APLD) is currently trading around $27.40 ahead of earnings, fresh off highs of $29.26, reflecting a an impressive 250% gain since the start of the year. A new high into the earnings release on

Joby Aviation (NYSE: JOBY) witnessed an 8.2% decline in its stock price overnight, moving sharply lower following the announcement of a $513.9 million underwritten public offering of common stock. This offering, initially int

AST SpaceMobile stock (NADSAQ: ASTS) has given holders a turbulent trading day in the markets, declining early following a downgrade from Scotiabank and the announcement of a significant equity distribution agreement. 

The AdvisorShares Pure US Cannabis ETF (MSOS) is demonstrating continued strength, building on recent gains as favorable developments in the regulatory and political landscape buoy the cannabis sector. The ETF has surged 14.5

TransMedics Group, Inc. (NASDAQ: TMDX) Q3 financials have been unveiled and recent analyst commentary suggests a potential revenue shortfall in the near term, while maintaining a positive long-term outlook. This divergence pa

AstraZeneca (LON:AZN) has announced positive results from its Phase III Bax24 trial, showcasing the efficacy of baxdrostat in reducing blood pressure in patients with treatment-resistant hypertension. The stock experienced a